Plasticity of kidney cells: Role in kidney remodeling and scarring

Kidney International

Volumn 64, Issue 5, 2003, Pages 1553-1563

  El Nahas, A Meguid ^a,b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Glomerulosclerosis; Plasticity; Stem cells; Tubulointerstitial fibrosis

Indexed keywords

NITRIC OXIDE SYNTHASE; SMAD7 PROTEIN;

BONE MARROW CELL; CELL DAMAGE; CELL DIFFERENTIATION; CELL MATURATION; CYTOKINE RELEASE; EMBRYO CELL; ENZYME ACTIVITY; GLOMERULOSCLEROSIS; HEMATOPOIETIC STEM CELL; INTERSTITIAL NEPHRITIS; KIDNEY SCAR; KIDNEY TUBULE CELL; LEUKOCYTE ADHERENCE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCAR FORMATION; STEM CELL;

EID: 0142156139     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00255.x     Document Type: Article

References (69)

1. XUE JL, MA JZ, LIU TA, COLLINS AJ: Forecast of the number of patients with en stage renal disease in the United States to the year 2110. J Am Soc Nephrol 12:2753-2758, 2001
2. JOHNSON RJ: The glomerular response to injury: progression or resolution? Kidney Int 45:1769-1782, 1994
3. CAMPBELL RC, RUGGENENTI P, REMUZZI G: Halting the progression of chronic nephropathy. J Am Soc Nephrol 13:S190-S195, 2002
4. ANDERS HJ, VIELHAUER V, SCHLONDORFF D: Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 63:401-415, 2003
5. EDDY AA: Molecular basis of renal fibrosis. Pediatr Nephrol 15: 290-301, 2000
6. JOHNSON TS, GRIFFIN M, THOMAS GL, et al: A. The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. J Clin Invest 99:2950-2960, 1997
7. SAVAGE COS: The biology of the glomerulus: Endothelial cells. Kidney Int 45:314-319, 1994
8. CATTELL V: Nitric oxide and glomerulonephritis. Kidney Int 61:816-821, 2002
9. KANG DH, NAKAGAWA T, FENG L, JOHNSON RJ: Nitric oxide modulates vascular disease in the remnant kidney model. Am J Pathol 161:239-248, 2002
10. KANG DH, JOHNSON RJ: Vascular endothelial growth factor: A new player in the pathogenesis of renal fibrosis. Curr Opin Nephrol Hypertens 12:43-49, 2003
11. JOHNSON RJ, FLOEGE J, YOSHIMURA A, et al: The activated mesangial cell: A glomerular "myofibroblast." J Am Soc Nephrol 2(Suppl 10):S190-S197, 1992
12. EL NAHAS AM, MUCHANETA-KUBARA EC, ESSAWY M, SOYLEMEZOGLU O: Renal fibrosis: Insights into pathogenesis and treatment. Int J Biochem Cell Biol 29:55-62, 1997
13. HUGO C, SHANKLAND SJ, BOWEN-POPE DF, JOHNSON RJ: Extraglomerular origin of the mesangial cells after injury. J Clin Invest 100: 786-794, 1997
14. JOHNSON RJ, IDA H, ALPERS CE, et al: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest 87:847-858, 1991
15. LINDHAL P, HELLSTROM M, KALEN M, et al: Paracrine PDGF-B/PDGF-R beta signalling controls mesangial development in kidney glomeruli. Development 125:3313-3322, 1998
16. NARUSE K, FUJIEDA M, MIYAZAKI E, et al: CD34 expression as a novel marker of transformed mesangial cells in biopsied glomerular diseases. J Pathol 189:105-111, 1999
17. SIMMONS PJ, TOROK-STORB B: CD34 expression by stromal precursors in normal human adult bone marrow. Blood 78:2848-2853, 1991
18. EL NAHAS AM, MUCHANETA-KUBARA EC, ZHANG G, et al: Phenotypic modulation of renal cells in experimental and clinical renal scarring. Kidney Int 49(Suppl 54):S23-S27, 1996
19. GOUMENOS D, BROWN CB, SHORTLAND J, EL NAHAS AM: Myofibroblasts, predictors of progression of mesangial IgA nephropathy? Nephrol Dial Transpl 9:1418-1425, 1994
20. SANAI T, SOBKA T, JOHNSON T, et al: Expression of cytoskeletal proteins during the course of experimental diabetic nephropathy. Diabetologia 43:91-100, 2000
21. ESSAWY M, SOYLEMEZOGLU O, MUCHANETA-KUBARA EC, et al: Myofibroblasts and the progression of diabetic nephropathy. Nephrol Dial Transpl 12:43-50, 1997
22. IMAI E, ISAKA Y, FUJIWARA Y, et al: Introduction of a foreign gene into the kidney in vivo: Development of glomerulosclerosis by the transfection of gene for PDGF and TGF-beta. Contrib Nephrol 107:205-215, 1994
23. BASILE DP: The transforming growth factor beta system in kidney disease and repair: Recent progress and future directions. Curr Opin Nephrol Hypertens 8:21-30, 1999
24. KAGAMI S, KONDO S, URUSHIHARA M, et al: Overexpression of alpha1beta1 integrin directly affects rat mesangial cell behaviour. Kidney Int 58:1088-1097, 2000
25. MOONEY A, JACKSON K, BACON R, et al: Type IV collagen and laminin regulate glomerular mesangial cell susceptibility to apoptosis via beta(1) integrin-mediated survival signals. Am J Pathol 155: 599-606, 1999
26. KITAMURA M, FINE LG: Evidence for TGF-beta-mediated "defense" of the glomerulus: Blackguard molecule rehabilitated? Exp Nephrol 6:1-6, 1998
27. SCHNAPER HW, HAYASHIDA T, HUBSCHAK SC, PONCELET AC: TGF-beta signal transduction and mesangial cell fibrogenesis. Am J Physiol 284:F243-F252, 2003
28. PONCELET AC, DE CAESTECKER MP, SCHNAPER HW: The transforming growth factor-beta/SMAD signalling pathway is present and functional in human mesangial cells. Kidney Int 56:1354-1365, 1999
29. SCHIFFER M, SCHIFFER LE, GUPTA A, et al: Inhibitory Smads and TGF-beta signalling in glomerular cells. J Am Soc Nephrol 13:2657-2666, 2002
30. CHEN Y, BLOM IE, SA S, et al: CTGF expression in mesangial cells: involvement of SMADs, MAP kinase, and PKC. Kidney Int 62:1149-1159, 2002
31. GOLDSCHMEDING R, ATEN J, ITO Y, et al: Connective tissue growth factor: just another factor in renal fibrosis? Nephrol Dial Transplant 15:296-299, 2000
32. NG YY, FAN JM, MU W, et al: Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transpl 14:2860-2872, 1999
33. LE HIR M, KELLER C, ESCHMANN V, et al: Podocyte bridges between the tuft and Bowman's capsule: an early event in experimental crescentic glomerulonephritis. J Am Soc Nephrol 12:2060-2071, 2001
34. ABBATE M, ZOJA C, MORIGI M, et al: Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis. Am J Pathol 161:2179-2193, 2002
35. SCHIFFER M, BITZER M, ROBERTS ISD, et al: Apoptosis in podocytes induced by TGF-β and Smad7. J Clin Invest 108:807-816, 2001
36. PAVENSTADT KW, KRETZLER M: Cell biology of the glomerular podocyte. Physiol Rev 83:253-307, 2003
37. AL-AWQATI Q, OLIVER JA: Stem cells in the kidney. Kidney Int 61:387-395, 2002
38. ITO T, SUZUKI A, IMAI E, et al: Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodelling. J Am Soc Nephrol 12:2625-2635, 2001
39. DONOVAN PJ, GEARHART J: The end of the beginning for pluripotent stem cells. Nature 414:92-97, 2001
40. IMASAWA T, UTSUNOMIYA Y, KAWAMURA T, et al: The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. J Am Soc Nephrol 12:1401-1409, 2001
41. HASELY LA, HUGO C, REIDY MA, JOHNSON RJ: Dissociation of mesangial cell migration and proliferation in experimental glomerulonephritis. Kidney Int 56:964-972, 1999
42. CORNACCHIA F, FORNONI A, PLATI AR, et al: Glomerulosclerosis is transmitted by bone marrow-derived mesangial cell progenitors. J Clin Invest 108:1649-1656, 2001
43. IMASAWA T, NAGASAWA R, UTSUNOMIYA Y, et al: Bone marrow transplantation attenuates murine IgA nephropathy: Role of a stem cell disorder. Kidney Int 56:1809-1817, 1999
44. ITO T, SUZUKI A, OKABE M, et al: Application of bone marrow-derived stem cells in experimental nephrology. Exp Nephrol 9:444-450, 2001
45. IMAI E, ITO T: Can bone marrow differentiate into renal cells? Pediatr Nephrol 17:790-794, 2002
46. PETERSEN BE, TERADA N: Stem cells: A journey into a new frontier. J Am Soc Nephrol 12:1773-1780, 2001
47. EL-KORAIE AF, BADDOUR NM, ADAM AG, et al: Role of stem cell factor and mast cells in the progression of chronic glomerulonephritides. Kidney Int 60:167-172, 2001
48. JERNIGAN SJ, EDDY AA: Experimental insights into the mechanisms of tubulointerstitial scarring, in Mechanism and Management of Progressive Renal Failure, edited by EL NAHAS AM, ANDERSON S, HARRIS KPG, London, Oxford University Press, 2000, pp 104-145
49. FAN JM, NG YY, HILL PA, et al: Transforming growth factor-beta regulates tubular epithelial myofibroblast transdifferentiation in vitro. Kidney Int 56:1455-1467, 1999
50. ZEISBERG M, STRUTZ F, MULLER GA: Renal fibrosis: an update. Curr Op Nephrol Hypert 10:315-320, 2000
51. OLDFIELD MD, BACH LA, FORBES JM, et al: Advanced glycation end products cause epithelial-myoflbroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 108:1853-1863, 2001
52. IWANO M, PLIETH D, DANOFF TM, et al: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341-350, 2002
53. SAPPINO AP, SCHURCH W, GABBIANI G: Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 63:144-161, 1990
54. STRUTZ F, ZEISBERG M, ZIYADEH FN, et al: Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 61:1714-1728, 2002
55. YANG J, LIU Y: Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 159:1465-1475, 2001
56. YANG J, LIU Y: Blockade of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 13:96-107, 2002
57. YANG J, LIU Y: Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy. Am J Physiol 284:F349-F357, 2003
58. ZEISBERG M, BONNER G, MAESHIMA Y, et al: Renal fibrosis: Collagen composition and assembly regulates epithelial-mesenchymal trans-differentiation. Am J Pathol 159:1313-1321, 2001
59. WIJESEKERA DS, ZARAMA MJ, PALLER MS: Effects of integrins on proliferation and apoptosis of renal epithelial cells after acute injury. Kidney Int 52:1511-1520, 1997
60. THOMAS GL, YANG B, WAGNER B, et al: Cellular apoptosis and proliferation in experimental renal fibrosis. Nephrol Dial Transpl 13:2216-2226, 1998
61. DESMOULIERE A, BADID C, BOCHATON-PIALLAT ML, GABBIANI G: Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury. Int Biochem Cell Biol 29:19-30, 1997
62. GUPTA S, VERFAILLE C, CHMIELEWSKI D, et al: A role for extrarenal cells in the regeneration following acute renal failure. Kidney Int 62:1285-1290, 2002
63. POULSOM R, FORBES SJ, HODIVALA-DILKE K, et al: Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 195:229-235, 2001
64. LIN F, CORDES K, LI L, et al: Haematopoietic stem cells contribute to regeneration of renal tubules after ischemia-reperfusion injury in mice. J Am Soc Nephrol 14:1188-1199, 2003
65. MEDVISNKY A, SMITH A: Stem cells: Fusion brings down barriers. Nature 422:823-825, 2003
66. JIANG Y, VAESSEN B, LENVIK T, et al: Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle and brain. Exp Haematol 30:896-904, 2002
67. EL KOSSI M, EL NAHAS AM: Stem cell factor and crescentic glomerulonephritis. Am J Kidney Dis 41:785-795, 2003
68. Huss R: Perspectives on the morphology and biology of CD34-negative stem cells. J Hematother Stem Cell Res 9:783-793, 2000
69. LI JH, ZHU HJ, HUANG XR, et al: Smad7 inhibits fibrotic effects of TGF-β on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol 13:1464-1472, 2002